RE-BVS – Piemonte Repository

Sfoglia per AUTORE
CALDANO M
Collezione AOU San Luigi di Orbassano

Items : 19

Study of the NR4A family gene expression in patients with multiple sclerosis treated with Fingolimod. in European journal of neurology / Eur J Neurol. 2019 Apr;26(4):667-672. doi: 10.1111/ene.13875. Epub 2018 Dec 22.

2019
AOU San Luigi di Orbassano

Montarolo F; Perga S; Martire S; Brescia F; Caldano M; Lo Re M; Panzica G; Bertolotto A;

The Soluble Form of Toll-Like Receptor 2 Is Elevated in Serum of Multiple Sclerosis Patients: A Novel Potential Disease Biomarker. in Frontiers in immunology / Front Immunol. 2018 Mar 14;9:457. doi: 10.3389/fimmu.2018.00457. eCollection 2018.

2018
AOU San Luigi di Orbassano

Hossain MJ; Morandi E; Tanasescu R; Frakich N; Caldano M; Onion D; Faraj TA; Erridge C; Gran B;

Detection of potassium channel KIR4.1 antibodies in Multiple Sclerosis patients. in Journal of immunological methods / J Immunol Methods. 2017 Jun;445:53-58. doi: 10.1016/j.jim.2017.03.008. Epub 2017 Mar 12.

2017
AOU San Luigi di Orbassano

Marnetto F; Valentino P; Caldano M; Bertolotto A;

Role of Anti-Osteopontin Antibodies in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis. in Frontiers in immunology / Front Immunol. 2017 Mar 23;8:321. doi: 10.3389/fimmu.2017.00321. eCollection 2017.

2017
AOU San Luigi di Orbassano

Clemente N; Comi C; Raineri D; Cappellano G; Vecchio D; Orilieri E; Gigliotti CL; Boggio E; Dianzani C; Sorosina M; Martinelli-Boneschi F; Caldano M; Bertolotto A; Ambrogio L; Sblattero D; Cena T; Leone M; Dianzani U; Chiocchetti A;

Natalizumab treatment reduces L-selectin (CD62L) in CD4+ T cells. in Journal of neuroinflammation / J Neuroinflammation. 2015 Aug 12;12:146. doi: 10.1186/s12974-015-0365-x.

2015
AOU San Luigi di Orbassano

Spadaro M; Caldano M; Marnetto F; Lugaresi A; Bertolotto A;

Biological monitoring of IFN-? therapy in Multiple Sclerosis. in Cytokine & growth factor reviews / Cytokine Growth Factor Rev. 2015 Apr;26(2):241-8. doi: 10.1016/j.cytogfr.2014.12.002. Epub 2014 Dec

2015
AOU San Luigi di Orbassano

Bertolotto A; Granieri L; Marnetto F; Valentino P; Sala A; Capobianco M; Malucchi S; Di Sapio A; Malentacchi M; Matta M; Caldano M;

Vitamin D Binding Protein Isoforms and Apolipoprotein E in Cerebrospinal Fluid as Prognostic Biomarkers of Multiple Sclerosis. in PloS one / PLoS One. 2015 Jun 5;10(6):e0129291. doi: 10.1371/journal.pone.0129291. eCollection 2015.

2015
AOU San Luigi di Orbassano

Perga S; Giuliano Albo A; Lis K; Minari N; Falvo S; Marnetto F; Caldano M; Reviglione R; Berchialla P; Capobianco MA; Malentacchi M; Corpillo D; Bertolotto A;

One-year evaluation of factors affecting the biological activity of interferon beta in multiple sclerosis patients. in Journal of neurology / J Neurol. 2011 May;258(5):895-903. doi: 10.1007/s00415-010-5844-5. Epub 2010 Dec 12.

2011
AOU San Luigi di Orbassano

Malucchi S; Gilli F; Caldano M; Sala A; Capobianco M; di Sapio A; Granieri L; Bertolotto A;

Loss of braking signals during inflammation: a factor affecting the development and disease course of multiple sclerosis. in Archives of neurology / Arch Neurol. 2011 Jul;68(7):879-88. doi: 10.1001/archneurol.2011.32. Epub 2011 Mar 14.

2011
AOU San Luigi di Orbassano

Gilli F; Navone ND; Perga S; Marnetto F; Caldano M; Capobianco M; Pulizzi A; Malucchi S; Bertolotto A;

Predictive markers for response to interferon therapy in patients with multiple sclerosis. in Neurology / Neurology. 2008 Mar 25;70(13 Pt 2):1119-27. doi: 10.1212/01.wnl.0000304040.29080.7b. Epub 2008 Feb 1

2008
AOU San Luigi di Orbassano

Malucchi S; Gilli F; Caldano M; Marnetto F; Valentino P; Granieri L; Sala A; Capobianco M; Bertolotto A;

Expression and regulation of IFNalpha/beta receptor in IFNbeta-treated patients with multiple sclerosis. in Neurology / Neurology. 2008 Dec 9;71(24):1940-7. doi: 10.1212/01.wnl.0000327340.50284.8d. Epub 2008 Oct 29.

2008
AOU San Luigi di Orbassano

Gilli F; Valentino P; Caldano M; Granieri L; Capobianco M; Malucchi S; Sala A; Marnetto F; Bertolotto A;

Anti-interferon-beta neutralising activity is not entirely mediated by antibodies. in Journal of neuroimmunology / J Neuroimmunol. 2007 Dec;192(1-2):198-205. doi: 10.1016/j.jneuroim.2007.09.025. Epub 2007 Oct 22.

2007
AOU San Luigi di Orbassano

Gilli F; Marnetto F; Caldano M; Valentino P; Granieri L; Di Sapio A; Capobianco M; Sala A; Malucchi S; Kappos L; Lindberg RL; Bertolotto A;

Development and validation of a real time PCR-based bioassay for quantification of neutralizing antibodies against human interferon-beta. in Journal of immunological methods / J Immunol Methods. 2007 Apr 10;321(1-2):19-31. doi: 10.1016/j.jim.2006.12.012. Epub 2007 Feb 20.

2007
AOU San Luigi di Orbassano

Bertolotto A; Sala A; Caldano M; Capobianco M; Malucchi S; Marnetto F; Gilli F;

Biological markers of interferon-beta therapy: comparison among interferon-stimulated genes MxA, TRAIL and XAF-1. in Multiple sclerosis (Houndmills, Basingstoke, England) / Mult Scler. 2006 Feb;12(1):47-57. doi: 10.1191/135248506ms1245oa.

2006
AOU San Luigi di Orbassano

Gilli F; Marnetto F; Caldano M; Sala A; Malucchi S; Capobianco M; Bertolotto A;

Qualitative and quantitative analysis of antibody response against IFNbeta in patients with multiple sclerosis. in Multiple sclerosis (Houndmills, Basingstoke, England) / Mult Scler. 2006 Dec;12(6):738-46. doi: 10.1177/1352458506070968.

2006
AOU San Luigi di Orbassano

Gilli F; Hoffmann F; Sala A; Marnetto F; Caldano M; Valentino P; Kappos L; Bertolotto A; Lindberg RL;

Biological responsiveness to first injections of interferon-beta in patients with multiple sclerosis. in Journal of neuroimmunology / J Neuroimmunol. 2005 Jan;158(1-2):195-203. doi: 10.1016/j.jneuroim.2004.08.006.

2005
AOU San Luigi di Orbassano

Gilli F; Marnetto F; Caldano M; Sala A; Malucchi S; Di Sapio A; Capobianco M; Bertolotto A;

Fate of multiple sclerosis patients positive for neutralising antibodies towards interferon beta shifted to alternative treatments. in Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology / Neurol Sci. 2005 Dec;26 Suppl 4:S213-4. doi: 10.1007/s10072-005-0517-3.

2005
AOU San Luigi di Orbassano

Malucchi S; Capobianco M; Gilli F; Marnetto F; Caldano M; Sala A; Bertolotto A;

Biological activity of interferon betas in patients with multiple sclerosis is affected by treatment regimen and neutralising antibodies. in Journal of neurology, neurosurgery, and psychiatry / J Neurol Neurosurg Psychiatry. 2004 Sep;75(9):1294-9. doi: 10.1136/jnnp.2004.037259.

2004
AOU San Luigi di Orbassano

Bertolotto A; Sala A; Malucchi S; Marnetto F; Caldano M; Di Sapio A; Capobianco M; Gilli F;

Comparison of three PCR assays for the evaluation of interferon-beta biological activity in patients with multiple sclerosis. in Molecular diagnosis : a journal devoted to the understanding of human disease through the clinical application of molecular biology / Mol Diagn. 2004;8(3):185-94. doi: 10.1007/BF03260063.

2004
AOU San Luigi di Orbassano

Gilli F; Marnetto F; Stefanuto G; Rinaldi V; Farinazzo F; Malucchi S; Capobianco M; Caldano M; Sala A; Bertolotto A;